Biotech Products - Search News

Zacks.com on MSN · 19h

Bio-Techne Tops Q2 Earnings & Revenue Estimates, Stock Up in Premarket

Bio-Techne TECH reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of 42 cents, which exceeded the Zacks Consensus Estimate by 10.5%. The bottom line improved from the year-ago figure of 40 cents.

Business Insider · 1d

Bio-Techne Corp. Q2 Profit Increases, Beats Estimates

Bio-Techne Corp. (TECH) announced earnings for its second quarter that increased from last year and beat the Street estimates. The

Bio-Techne beats Q2 earnings estimates on improving demand for biotech products

Bio-Techne beat second-quarter profit and revenue estimates on Wednesday, helped by growth in its protein sciences unit that makes products to develop therapies

Seeking Alpha on MSN · 23h

Bio-Techne spikes as Q2 growth accelerates amid improving market conditions

Shares of Bio-Techne Corporation (NASDAQ:TECH) traded higher after the life sciences company topped analysts' expectations with its Q2 FY25 results, indicating a faster topline growth amid early signs of recovery in the biopharma end market.

Fierce Healthcare20h

Hospitals ask Trump to exempt medical, pharma products from tariffs

The hospital lobby is petitioning President Donald Trump to grant carve-outs for medical devices and pharmaceutical products ...

4h

China’s first counter-sanction on US biotech industry marks a turning point in tech war

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

Pushing the boundaries of biotechnology

Unnatural Products, a Santa Cruz-based biotech company founded by UC Santa Cruz alumni Cameron Pye and Joshua Schwochert ...

13d

Biotech Alert: Searches spiking for these stocks today

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

EC Launches Biotech and Biomanufacturing Hub to Support Innovative Companies

The European Commission (EC) announced on January 29, 2025, that it launched a Biotech and Biomanufacturing Hub to support companies — ...

7d

Ultragenyx Pharmaceutical: Advancing On Multiple Fronts

Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results